Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: Four out of twelve patients achieved complete remission (CR), one patient had a partial remission (PR), three were stable and four had disease progression under radio therapy and chemo- immunotherapy. Yet three pts. died of the disease. The toxicity symptoms according to WHO ranged between grade 2 and grade 3. CONCLUSION:
|
Authors | O A Brinkmann, F Bruns, F J Prott, L Hertle |
Journal | Anticancer research
(Anticancer Res)
1999 Mar-Apr
Vol. 19
Issue 2C
Pg. 1583-7
ISSN: 0250-7005 [Print] Greece |
PMID | 10365150
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Interferon-alpha
- Interleukin-2
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Agents
(therapeutic use)
- Bone Neoplasms
(secondary, therapy)
- Carcinoma, Renal Cell
(pathology, radiotherapy, therapy)
- Combined Modality Therapy
(adverse effects)
- Disease Progression
- Female
- Fluorouracil
(therapeutic use)
- Follow-Up Studies
- Humans
- Immunotherapy
- Interferon-alpha
(therapeutic use)
- Interleukin-2
(therapeutic use)
- Kidney Neoplasms
(pathology, radiotherapy, therapy)
- Male
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Time Factors
|